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Abstract 
Background: To evaluate the effects of acute hyperventilation on the central venous-to-arterial carbon dioxide ten-
sion difference (∆PCO2) in hemodynamically stable septic shock patients.
Methods: Eighteen mechanically ventilated septic shock patients were prospectively included in the study. We 
measured cardiac index (CI), ∆PCO2, oxygen consumption (VO2), central venous oxygen saturation (ScvO2), and blood 
gas parameters, before and 30 min after an increase in alveolar ventilation (increased respiratory rate by 10 breaths/
min).
Results: Arterial pH increased significantly (from 7.35 ± 0.07 to 7.42 ± 0.09, p < 0.001) and arterial carbon diox-
ide tension decreased significantly (from 44.5 [41–48] to 34 [30–38] mmHg, p < 0.001) when respiratory rate was 
increased. A statistically significant increase in VO2 (from 93 [76–105] to 112 [95–134] mL/min/m
2, p = 0.002) was 
observed in parallel with the increase in alveolar ventilation. While CI remained unchanged, acute hyperventilation led 
to a significant increase in ∆PCO2 (from 4.7 ± 1.0 to 7.0 ± 2.6 mmHg, p < 0.001) and a significant decrease in ScvO2 
(from 73 ± 6 to 67 ± 8%, p < 0.001). A good correlation was found between changes in arterial pH and changes in 
VO2 (r = 0.67, p = 0.002). Interestingly, we found a strong association between the increase in VO2 and the increase in 
∆PCO2 (r = 0.70, p = 0.001).
Conclusions: Acute hyperventilation provoked a significant increase in ∆PCO2, which was the result of a significant 
increase in VO2 induced by hyperventilation. The clinician should be aware of the effects of acute elevation of alveolar 
ventilation on ∆PCO2.
Keywords: Acute hyperventilation, Oxygen consumption, Central venous-to-arterial CO2 tension gap, Central venous 
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Background
Awareness that tissue hypoperfusion is a key factor 
in the pathogenesis of the multiple organ failures has 
focused the attention on surrogate indicators of tissue 
perfusion in the critically ill patient [1, 2]. In this context, 
venous-to-arterial carbon dioxide tension difference 
(∆PCO2) has been proposed as a marker of tissue hypop-
erfusion in patients with septic shock [3–9]. In fact, the 
increase in ∆PCO2 that has been observed in low-flow 
states is mainly related to venous hypercapnia, rather 
than a decrease in arterial CO2 partial pressure (PaCO2), 
which can be explained by the tissue CO2 stagnation phe-
nomenon. Indeed, due to the decrease in transit time, 
there is a higher than usual addition of CO2 per unit of 
blood passing the efferent microvessels, which leads to a 
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rise in CO2 partial pressure in the venous blood (PvCO2) 
[10–12].
The reason for the preferred use of ∆PCO2 over PvCO2 
as a marker of global tissue perfusion is that ∆PCO2 was 
found to be less influenced by changes in PaCO2 than 
PvCO2 [13–15]. However, acute changes in PaCO2 or 
arterial pH might have direct effects on microvascular 
tone and/or might induce variations in systemic oxygen 
consumption [15–18], and could then affect ∆PCO2. 
Recently, in healthy volunteers, acute hyperventila-
tion was shown to be associated with an increase in the 
peripheral venous-to-arterial CO2 difference due to a 
reduction in peripheral blood flow induced by acute 
hypocapnia [19, 20]. Furthermore, Morel et  al. [21] 
found, in a small study that included mechanically ven-
tilated postoperative patients, that acute decreases in 
PaCO2 resulted in significant increases in ∆PCO2 with-
out any change in cardiac output. Therefore, it is not clear 
so far what the impact of the rapid decrease in PaCO2 on 
∆PCO2 is. This question is important because if PaCO2 
or arterial pH fluctuations could influence ∆PCO2, this 
effect will have to be taken into account by the physician 
when interpreting ∆PCO2 at the bedside. The aim of this 
study was to investigate the impact of acute hyperventila-
tion on ∆PCO2 in mechanically ventilated and hemody-
namically stable septic shock patients.
Methods
This prospective and observational study was conducted 
in a single general adult intensive care unit (ICU). The 
study was approved by our local institutional ethics 
committee (Comité d’éthique du Centre Hospitalier du 
Dr. Shaffner de Lens, France). Informed consent was 
obtained from each subject’s next of kin.
Patients
The study included mechanically ventilated and hemody-
namically stable septic shock patients. The diagnosis of 
septic shock was defined according to the criteria of the 
American College of Chest Physicians (ACCP)/Society of 
Critical Care Medicine (SCCM) Consensus Conference 
[22]. All patients had to be monitored by a transpulmo-
nary thermodilution device (PiCCO, Pulsion Medical 
System, Munich, Germany) as part of routine manage-
ment of septic shock in our ICU.
To avoid spontaneous breathing activity, patients 
remained sedated throughout the study via continuous 
infusions of propofol and remifentanil. Patients were ven-
tilated in the control volume mode.
Exclusion criteria were pregnancy, age less than 
18  years old, unstable hemodynamic condition (change 
in vasoactive drug dosage or fluid administration within 
1  h preceding the protocol), high blood lactate levels 
(>2 mmol/L), and uncontrolled tachyarrhythmias (heart 
rate 140 beats/min).
Measurements
Demographic data, septic shock etiology, the Simplified 
Acute Physiology Score (SAPS) II, and the Sequential 
Organ Failure Assessment (SOFA) scores were obtained 
on the day of enrollment.
Cardiac index (CI) was obtained with the PiCCO moni-
tor by triplicate central venous injections, in either the 
internal jugular or subclavian vein, of 20 mL of iced 0.9% 
saline solution and recorded as the average of the three 
measurements. In cases where the discrepancy in CI 
measurements was >10%, the measurement was repeated 
two more times (five times in total) with elimination of 
the highest and the lowest results.
Arterial and central venous blood gases analy-
sis and arterial lactate levels were measured using 
the GEM Premier 4000 (Instrumentation Labora-
tory Co, Paris, France). To ensure accurate measure-
ment, the blood gas analyzer was calibrated several 
times a day. Central venous blood was obtained from a 
central venous catheter with the tip confirmed to be in 
the superior vena cava at the entrance, or in the right 
atrium, by X-ray. ∆PCO2 was calculated as the dif-
ference between central venous carbon dioxide ten-
sion (PcvCO2) and arterial carbon dioxide tension 
(PaCO2). Arterial oxygen content was calculated as 
CaO2 (mL) = 1.34 × Hb (g/dL) × SaO2 + 0.003 × PaO2 
(mmHg), where SaO2 is the oxygen saturation of arte-
rial blood, Hb the hemoglobin concentration, and PaO2 
the arterial oxygen tension. Central venous oxygen con-
tent was calculated as CcvO2 (mL)  =  1.34  ×  Hb (g/
dL) × ScvO2 + 0.003 × PcvO2 (mmHg), where PcvO2 is 
the central venous oxygen tension and ScvO2 the central 
venous oxygen saturation. DO2 was calculated by using 
the formula: DO2 (mL/min/m2) = CaO2 × CI × 10. VO2 
was calculated using the following formula: VO2 (mL/
m2) =  CI ×  (CaO2 −  CcvO2) ×  10. Oxygen extraction 
was defined as: OE = VO2/DO2.
Heart rate (HR), mean arterial pressure (MAP), minute 
ventilation, respiratory rate, body temperature, and frac-
tional inspired oxygen level were also recorded.
Study protocol
Patients were in steady state defined as less than 10% 
variation in HR, MAP, CI, and SaO2 over a 60-min 
period before baseline measurements were initiated. 
Each patient was quiet and well adapted to the respira-
tor. Fluid, doses of the vasopressor, and sedation drugs 
were kept constant in the hour preceding the measure-
ments and throughout the study period. Variations in 
body temperature must have been <±0.5 °C. Enteral and/
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or parenteral nutrition were continued and remained 
unchanged during the data collection period.
At baseline, a first set of measurements was performed, 
including hemodynamic and tissue oxygenation variables 
(HR, MAP, CI, VO2, ScvO2), arterial lactate level, ∆PCO2, 
respiratory rate, and minute ventilation. Alveolar venti-
lation was then increased by raising the respiratory rate 
by 10 breaths/min (hyperventilation period). The inspir-
atory time was decreased to avoid the generation of an 
intrinsic positive end-expiratory pressure (PEEP) and 
to keep the level of plateau pressure constant through-
out the study period. Also, the external PEEP remained 
unchanged. After 30 min of stabilization, a second set of 
measurement was recorded, including the same hemo-
dynamic, respiratory, and tissue oxygenation variables 
(Additional file 1).
Changes in variables induced by the increase in alveo-
lar ventilation were expressed as relative changes: [(vari-
able after − variable before)/variable before] × 100.
Statistical analysis
Data are presented as mean ± SD or as median (25–75%, 
interquartile range). Normality was evaluated using the 
Shapiro–Wilk test. Comparisons of variables between 
before versus after increase in alveolar ventilation were 
assessed using Student’s paired t test or Wilcoxon test, 
as appropriate. Linear correlations were tested using the 
Pearson or the Spearman test, as appropriate. The McNe-
mar’s test was used to compare two paired proportions.
In a previous study [23], we found that the smallest 
detectable difference for ∆PCO2 was 2.0  mmHg. The 
smallest detectable difference is the minimum change (in 
absolute value) that needs to be measured by a labora-
tory analyzer in order to recognize a real change in meas-
urement. Thus, for a power of 90% and α risk of 0.05, a 
sample size of 17 was required to detect a mean differ-
ence of 2.0 mmHg in ∆PCO2 with a standard deviation of 
2.35 mmHg [23].
Statistical analysis was performed using STATA 14.0 
(StataCorp LP, College Station, Texas, USA). p < 0.05 was 
considered statistically significant. All reported p values 
are 2-sided.
Results
Eighteen septic shock patients were prospectively 
included in this study. Basic characteristics of the cohort 
are presented in Table 1. The principal source of infection 
was pneumonia (61%) with ICU mortality rate of 39%. All 
patients were sedated, mechanically ventilated without 
spontaneous breathing, and hemodynamically stable at 
their inclusions. No changes in vasopressor therapy and 
sedation level occurred during the observation period.
Effect of acute hyperventilation on blood gases, metabolic, 
and hemodynamic variables
Acute hyperventilation induced a significant increase in 
arterial pH and a significant decrease in PaCO2 (Table 2). 
Changes in arterial pH and PaCO2 were paralleled by a 
statistically significant increase in VO2 (Table 2). Cardiac 
index, heart rate, and DO2 remained unaffected.
Acute hyperventilation led to a significant increase 
in ∆PCO2, which resulted in a significant decrease 
in the number of patients with normal ∆PCO2 value 
(∆PCO2 ≤ 6 mmHg) (Table 2). Furthermore, we observed 
a significant reduction in ScvO2 in parallel to the increase 
in alveolar ventilation. Interestingly, lactate levels signifi-
cantly increased when minute ventilation was increased 
(Table  2). Abrupt elevation of alveolar ventilation was 
also associated with a significant increase in systemic 
vascular resistance index (Table 2).
Correlation analysis
We found a good correlation between the increase in 
arterial pH induced by hyperventilation and the increase 
in VO2 (r = 0.67, p = 0.002) (Fig. 1). Changes in PaCO2 
and VO2 were also moderately correlated (r  =  −0.54, 
p = 0.02).
The increase in ∆PCO2 observed after the elevation 
of alveolar ventilation was strongly associated with the 
increase in VO2 (r =  0.70, p =  0.001) (Fig.  2a). Also, a 
strong relationship was found between the increase in 
VO2 induced by hyperventilation and the decrease in 
ScvO2 (r = −0.83, p < 0.001) (Fig. 2b).
Table 1 Baseline characteristics of the patients (n = 18)
SAPS, simplified acute physiologic score; SOFA, sequential organ failure 
assessment; ICU, intensive care unit; FiO2, fractional inspired oxygen level; IQR, 
interquartile range; SD, standard deviation
Age (mean ± SD, years) 60 ± 10
Gender (men/women) 8/10
Body mass index [median (IQR), kg/m2] 26.5 [25.6–29.7]
SAPS II 54 ± 21
Admission SOFA score (mean ± SD) 11 ± 3
ICU mortality [n (%)] 7 (39)
FiO2 (mean ± SD, %) 50 ± 20
Hemoglobin [median (IQR), g/dL] 9.7 [9.0–10.2]
Norepinephrine [n (%)] 18 (100)
Norepinephrine [median (IQR), µg/kg/min) 0.26 [0.15–0.40]
Infection source [n (%)]
Pneumonia 11 (61)
Peritonitis 4 (22)
Urinary tract infection 2 (11)
Catheter/bloodstream 1 (6)
Mechanical ventilation [n (%)] 18 (100)
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We found that the increase in lactate levels after the 
acute increase in alveolar ventilation significantly corre-
lated with the increase in VO2 (r = 0.54, p = 0.02).
Hyperventilation-induced increase in systemic vas-
cular resistance index did not correlate with the change 
in ∆PCO2 (r = −0.20, p = 0.41), or the change in ScvO2 
(r = −0.13, p = 0.62).
Discussion
The main findings of our study were as follows: (1) acute 
increase in alveolar ventilation resulted in a signifi-
cant increase in ∆PCO2 accompanied with a significant 
decrease in ScvO2; (2) these changes were linked to a 
significant increase in oxygen consumption induced by 
acute hyperventilation.
Early identification and treatment of tissue hypoper-
fusion are critical factors in the management of septic 
shock patients. In this regard, ∆PCO2 has been consid-
ered as a marker that reflects the adequacy of tissue per-
fusion in septic shock states [3–9]. Increased ∆PCO2 is 
associated with venous hypercapnia, which is explained 
by the low-flow-induced CO2 stagnation phenomenon 
[11, 12]. Venous hypercapnia results from insufficient 
elimination of the CO2 produced by peripheral tissues, 
secondary to reductions in systemic and microcircula-
tory blood flow. However, under spontaneous breath-
ing, hyperventilation may decrease PaCO2 and thus may 
preclude the CO2 stagnation-induced increase in PvCO2 
[24]. Because alveolar hyperventilation would decrease 
both arterial and venous PCO2 without eliminating 
Table 2 Blood gases, hemodynamic, ventilation, and metabolic parameters before and after hyperventilation
PaCO2, partial arterial carbon dioxide tension; ∆PCO2, venous–arterial carbon dioxide tension difference; PaO2, partial arterial oxygen tension; FiO2, fractional inspired 
oxygen level; CI, cardiac index; MAP, mean arterial pressure; ScvO2, central venous oxygen saturation; DO2, oxygen delivery; VO2, oxygen consumption; OE, oxygen 
extraction; SVRI, systemic vascular resistance index; IQR, interquartile range; SD, standard deviation
Baseline Hyperventilation p value
PaCO2 [median (IQR), mmHg] 44 [41–48] 34 [30–38] <0.001
PcvCO2 [median (IQR), mmHg] 49 [46–53] 42 [38–44] <0.001
∆PCO2 (mean ± SD, mmHg) 4.7 ± 1.0 7.0 ± 2.6 <0.001
∆PCO2 ≤ 6 mmHg [n (%)] 17 (94.4) 8 (44.4) 0.004
Arterial pH (mean ± SD) 7.35 ± 0.07 7.42 ± 0.09 <0.001
Central venous pH (mean ± SD) 7.33 ± 0.07 7.39 ± 0.08 <0.001
Bicarbonate (mean ± SD, mmol/L) 25.6 ± 1.8 24.9 ± 1.6 <0.001
Base excess (mean ± SD, mmol/L) 0.1 ± 2.1 0.6 ± 2.1 0.002
PaO2/FiO2 (mean ± SD, mmHg) 210 ± 88 205 ± 92 0.64
CI (mean ± SD, L/min/m2) 3.03 ± 0.79 3.00 ± 0.78 0.27
Heart rate [median (IQR), beats/min] 85 [79–90] 86 [78–88] 0.70
Stroke index (mean ± SD, mL/m2) 36.2 ± 10.1 35.4 ± 10.3 0.25
MAP (mean ± SD, mmHg) 77 ± 8 79 ± 10 0.10
ScvO2 (mean ± SD, %) 73 ± 6 67 ± 8 <0.001
DO2 (mean ± SD, mL/min/m2) 396 ± 121 395 ± 114 0.62
VO2 [median (IQR), mL/min/m
2] 93 [76–105] 112 [95–134] 0.002
OE (mean ± SD, %) 24.5 ± 5.8 31.4 ± 8.1 <0.001
Lactate (mean ± SD, mmol/L) 1.15 ± 0.47 1.35 ± 0.50 <0.001
SVRI (mean ± SD, dynes s/m2/cm5) 1645 ± 379 1940 ± 464 <0.001
Tidal volume [median (IQR), mL] 455 [430–500] 450 [430–500] 0.08
Respiratory rate [median (IQR), breaths/min] 20 [18–20] 30 [28–30] <0.001
Minute ventilation (mean ± SD, L/min) 8.3 ± 1.6 12.6 ± 2.2 <0.001
Plateau pressure (mean ± SD, cm H2O) 23.5 ± 3.7 23.1 ± 4.7 0.60
Temperature (mean ± SD, °C) 37.1 ± 0.6 37.2 ± 0.6 0.21
Fig. 1 Relationship between changes in VO2 and changes in pH 
induced by the increase in alveolar ventilation
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the increased venous-to-arterial PCO2 gap, it is rec-
ommended to assess ∆PCO2 rather than only monitor 
PvCO2 as a global marker of tissue perfusion [25].
However, a few studies have assessed the effects of 
acute hyperventilation on ∆PCO2 in critically ill patients 
[13, 14, 21]. We found that the acute increase in alveo-
lar ventilation led to a significant increase in ∆PCO2 
with an amplitude (2.2  mmHg) that was larger than its 
smallest detectable difference (2.0 mmHg) [23]. In addi-
tion, when the changes in ∆PCO2 are expressed as rela-
tive changes, acute hyperventilation induced a significant 
increase in ∆PCO2 with a magnitude (48.5%) that was 
also greater than its least significant change (32.4%) [23], 
which is the minimum change that needs to be meas-
ured by a laboratory analyzer in order to recognize a real 
change in measurement. In other words, the observed 
increase in ∆PCO2 can be considered as a true change 
and was not due to a random variation. Our findings are 
in agreement with the results of Morel et al. [21]. Indeed, 
these authors studied the effects of an acute decrease in 
PaCO2, obtained by increasing the respiratory rate, on 
∆PCO2 in mechanically ventilated post-cardiac surgery 
patients. They found that acute hyperventilation pro-
voked a significant increase in ∆PCO2 (from 4.2  ±  1.8 
to 7.6 ±  1.7  mmHg), while the cardiac index was unaf-
fected. In that study [21], ScvO2 also decreased in paral-
lel with the increase in alveolar ventilation. Furthermore, 
in an animal study [16], the gradient between gastric 
mucosal PCO2 and PaCO2 (indicator of gut perfusion), 
obtained with gastric tonometry, increased significantly 
after hyperventilation. However, our results disagree 
with those of a previous study [13] that found no impact 
of hyperventilation on mixed venous-to-arterial PCO2 
difference in mechanically ventilated patients. In that 
study, the increase in alveolar ventilation was obtained 
very progressively by increasing the tidal volume from 7 
to 10  mL/kg over a period of 3  h, which might explain 
the absence of changes in mixed venous-to-arterial PCO2 
difference. Also, the mean cardiac index at baseline was 
high (4.55  ±  0.90  mL/min/m2), which would have pre-
vented any increase in mixed venous-to-arterial PCO2 
difference by washing out any addition of CO2 from the 
peripheral circulation.
Several mechanisms can be suggested to explain the 
increase in ∆PCO2 observed in our study. A first poten-
tial explanation is that acute hyperventilation provoked 
the increase in systemic oxygen consumption and there-
fore CO2 production. Thus, for a given venous blood 
flow, the increase in tissue CO2 production should 
lessen the decrease in PcvCO2 (induced by hyperventi-
lation) relatively to the decrease in PaCO2, leading to a 
rise in ∆PCO2. We believe that such a mechanism may 
have contributed to the increase in ∆PCO2 after acute 
hyperventilation in our study. Indeed, we observed a 
strong correlation between the increases in VO2 between 
before and after hyperventilation and the increases in 
∆PCO2 (Fig. 2a). Also, the magnitude of the decrease in 
PcvCO2 after hyperventilation was significantly less than 
the decrease in PaCO2 (−16.5 ±  4.8 vs. −22.7  ±  5.5%, 
p < 0.001, respectively), explaining the observed increase 
in ∆PCO2. Similarly, the reduction in ScvO2 found after 
hyperventilation can be explained by the increase in VO2. 
It is unlikely that the increase in VO2 with hyperventila-
tion was a result of an unstable state because of the lack 
of hemodynamic and temperature differences (Table  2), 
and the absence of changes in vasopressor and seda-
tion drugs during the study period. We think that the 
observed increase in VO2 was induced by acute hyper-
ventilation since we found a good association between 
changes in pH and changes in VO2 (Fig.  1). Acute res-
piratory alkalosis has been found, in some experiments 
in animals and humans, to increase VO2 and CO2 pro-
duction independently of any significant hemody-
namic changes [17, 18, 26, 27]. Indeed, hyperventilation 
Fig. 2 Relationship between changes in VO2 and the changes in ∆PCO2 (a) and ScvO2 (b) between after and before the increase in alveolar ventila-
tion
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alkalosis, in mechanically ventilated dogs, increased VO2 
by 10–25% [17, 18]. In anesthetized paralyzed patients, 
contradictory findings were observed with some authors 
reporting a significant increase in whole-body VO2 [27], 
whereas others failed to demonstrate any significant vari-
ation [14]. Recently, Morel et al. [20], reported a twofold 
increase in VO2 in healthy volunteers with hypocapnic 
condition compared to hypercapnic condition for the 
same minute volume, suggesting a possible contribution 
of this mechanism to the observed increase in peripheral 
venous-to-arterial CO2 difference after induced acute 
respiratory alkalosis. The mechanism by which an acute 
respiratory alkalosis stimulates oxygen consumption is 
unclear and may involve many intracellular processes. 
A decrease in intracellular hydrogen ion concentra-
tion may stimulate the activity of phosphofructokinase, 
a key enzyme in the glycolytic cycle, which could result 
in increased intracellular adenosine triphosphate (ATP) 
hydrolysis and increased VO2 [28, 29]. Interestingly, 
we found a significant increase in lactate level induced 
by acute hyperventilation (Table  2). This finding could 
be an indirect marker supporting the activation of the 
phosphofructokinase enzyme and the increased rate of 
glycolysis in our study. Indeed, several studies reported 
increased lactate production with alkalosis [30, 31], 
reflecting increased glycolysis.
A second possibility is that acute hypocapnia resulted 
in systemic vasoconstriction, thus decreasing the elimi-
nation of the total CO2 produced by the peripheral tis-
sues, and increasing the ∆PCO2. It has been shown that 
acute hypocapnia induces vasoconstrictive responses 
in various organs [14, 32, 33]. In healthy volunteers, 
Umeda et  al. [19] observed that acute hyperventila-
tion decreased both the minimal and mean flow veloc-
ity in the radial artery assessed by Doppler echography. 
The authors concluded that the decrease in mean blood 
flow, which was the result of increased vascular tone 
induced by hyperventilation, was responsible for the rise 
in peripheral venous-to-arterial CO2 difference that they 
observed after acute hyperventilation. Similarly, Morel 
et al. [20] found a significant drop in the skin microcir-
culatory blood flow of healthy volunteers, evaluated with 
in  vivo reflectance confocal microscopy, secondary to 
acute hypocapnia. In our study, we observed a signifi-
cant increase in systemic vascular resistance in paral-
lel with the elevation of alveolar ventilation (Table  2). 
Nevertheless, changes in systemic vascular resistance 
were not significantly correlated with changes in ∆PCO2 
nor with changes in ScvO2, which suggests, indirectly, a 
minimal participation of this mechanism to the increase 
in ∆PCO2. However, since we did not specifically evalu-
ate the microcirculation we cannot eliminate or confirm 
the contribution of the vasoconstrictive mechanism 
to the observed increase in ∆PCO2 secondary to acute 
hyperventilation.
A third possibility of the increase in ∆PCO2 is that 
acute hyperventilation could induce variations in the 
PCO2/CO2 content relationship. This mechanism is, 
however, unlikely to have occurred in our patients. 
Indeed, the relationship between CO2 content and PCO2, 
which is curvilinear rather than linear, is influenced 
by many factors such as the degree of metabolic acido-
sis, the hematocrit, and the oxygen saturation (Haldane 
effect) [12, 34]. Our patients did not have metabolic aci-
dosis, and acute hyperventilation did not change the base 
excess meaningfully (Table  2). Although venous oxygen 
saturation decreased significantly after acute hyperventi-
lation, it is unlikely that this change could have affected 
the PCO2/CO2 content relationship, because first, it was 
not large; in this extent as stressed by Jakob et  al. [35], 
changes in ∆PCO2 might not parallel changes in CO2 
content differences under conditions of very low values of 
venous oxygen saturation (<30%), which was not the case 
in our patients. Second, if Haldane effect had affected the 
PCO2/CO2 content relationship, it would have resulted in 
a decrease in ∆PCO2, rather than an increase in ∆PCO2 
[36].
Our results are of clinical importance. Indeed, changes 
in ventilator settings are regularly needed in mechani-
cally ventilated patients. Since ∆PCO2 is now widely rec-
ognized as a valuable marker to evaluate tissue perfusion 
in septic shock, a clinician should be aware that acute 
changes in pH or PaCO2 induced by hyperventilation 
could impact ∆PCO2 independently of changes in tissue 
perfusion. These findings should not dismiss the clinical 
value of ∆PCO2 as a marker to detect tissue perfusion 
derangements. On the contrary, our results highlighted 
the usefulness of ∆PCO2, as an index of VCO2/cardiac 
output ratio, to detect the imbalance between the relative 
increase in VCO2 and the blood flow, whatever the mech-
anism of this imbalance is (increases in oxygen consump-
tion [37, 38] or tissue hypoperfusion [9]).
We acknowledge some limitations to our study. First, 
the number of patients studied was small, but the study 
was sufficiently powered to detect a real change in 
∆PCO2 induced by hyperventilation. Second, the study 
was performed in a sample of septic shock patients from 
a single center, potentially limiting the generalizability 
of the results. However, our results confirm those of a 
previous study performed in a different patient popula-
tion (post-cardiovascular surgery patients) [21]. Third, 
VO2 was calculated from central venous oxygen satura-
tion and not from mixed venous oxygen saturation or 
measured by indirect calorimetry, what might limit its 
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accuracy. However, in our study, we were interested in 
investigating the changes in VO2 induced by acute hyper-
ventilation rather than by its absolute value. Further-
more, it has recently been demonstrated that calculating 
the oxygen-derived variables from the central venous 
blood allowed the detection of global tissue hypoxia in 
critically ill patients [39, 40]. Finally, we did not evalu-
ate the microcirculation, and thus, we were incapable of 
drawing any conclusions about the effects of acute hyper-
ventilation on the local vascular tone and its relationship 
to ∆PCO2.
Conclusion
In stable septic shock patients, acute hyperventila-
tion leads to a significant increase in ∆PCO2, which 
is associated with an increase in VO2, also induced by 
hyperventilation. Microcirculatory dysfunction is a 
key pathological mechanism involved in  septic shock 
patients and could, also, be exacerbated by acute changes 
in alveolar ventilation. This finding should be taken into 
account when interpreting ∆PCO2 at the bedside. Fur-
ther studies are needed to investigate the effects of acute 
hyperventilation on systemic oxygen consumption and 
local vascular tone.
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